Outlook Therapeutics Appoints Laura Cantrell as Vice President of Corporate Strategy and Business Development
ISELIN, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the...
